Skip to main content

Colic

1
Pipeline Programs
5
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Menarini
MenariniGermany - Dresden
1 program
1
NepadutantPhase 21 trial
Active Trials
NCT01532518Completed27Est. Jul 2012
Medica Corp
Medica CorpMA - Bedford
1 program
Bactecal® D LiquidN/A1 trial
Active Trials
NCT05052476Completed68Est. Oct 2023
Abbott
AbbottABBOTT PARK, IL
1 program
Experimental Infant formulaN/A1 trial
Active Trials
NCT02586558Terminated1Est. Aug 2019
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Nutramigen with EnfloraN/A1 trial
Active Trials
NCT01279265Completed30Est. Jan 2013
Boehringer Ingelheim
Boehringer IngelheimINGELHEIM, Germany
1 program
Hyoscine butylbromidePHASE_21 trial
Active Trials
NCT02242292Completed527

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MenariniNepadutant
Boehringer IngelheimHyoscine butylbromide
Medica CorpBactecal® D Liquid
AbbottExperimental Infant formula
Johnson & JohnsonNutramigen with Enflora

Clinical Trials (5)

Total enrollment: 653 patients across 5 trials

NCT01532518MenariniNepadutant

Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance

Start: Aug 2011Est. completion: Jul 201227 patients
Phase 2Completed
NCT02242292Boehringer IngelheimHyoscine butylbromide

Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort

Start: Apr 2006527 patients
Phase 2Completed
NCT05052476Medica CorpBactecal® D Liquid

First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic

Start: Apr 2022Est. completion: Oct 202368 patients
N/ACompleted
NCT02586558AbbottExperimental Infant formula

Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants

Start: Dec 2017Est. completion: Aug 20191 patients
N/ATerminated
NCT01279265Johnson & JohnsonNutramigen with Enflora

Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic

Start: Sep 2011Est. completion: Jan 201330 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.